Search By

Format
Articles (112)Events (25)News (1703)Interviews (84)
Publication Date

1,703 Results

Search By

ArticlesEventsNewsInterviews

Novo Nordisk's Late-Stage Cardiovascular Drug Fails Key Trial, Shares Drop

Novo Nordisk's ziltivekimab fails to significantly reduce cardiovascular risk in a Phase III trial, sending shares down 7.3%.

Simantini Singh Deo | Aug 03, 2026

Ascentage Pharma Appoints Faiçal Miyara As Chief Business Officer And Jim Ziegler As Chief Commercial Officer

Ascentage Pharma names Dr. Faiçal Miyara as CBO and Jim Ziegler as CCO to drive its global business development and commercial expansion.

Simantini Singh Deo | Aug 03, 2026

Novartis Wins FDA Approval For Pluvicto In Earlier Stage Metastatic Prostate Cancer, Expanding Patient Access

Novartis wins FDA approval for Pluvicto in earlier-stage metastatic hormone-sensitive prostate cancer, nearly doubling eligible patients.

Simantini Singh Deo | Aug 01, 2026

XORTX Therapeutics Appoints Financial Services Veteran Depesh Narotam As Independent Director

XORTX Therapeutics appoints Depesh Narotam, a 20-year financial services veteran, as an independent director to its Board.

Simantini Singh Deo | Aug 01, 2026

Rose Hill Life Sciences Appoints Biopharma Veteran Jama Pitman As CEO To Lead Psilocybin Therapy Development

Rose Hill Life Sciences names Jama Pitman, a 25-year biopharma veteran, as CEO to lead its psilocybin-based clinical programs.

Simantini Singh Deo | Aug 01, 2026

Profusa Signs Option Agreement To Acquire G3 Vision Labs And Build Public Diagnostics Business With $111 Million Revenue Base

Profusa signs an Option Agreement to acquire G3 Vision Labs, aiming to build a public diagnostics business on a $111 million revenue base.

Simantini Singh Deo | Aug 01, 2026

Vistagen Appoints Neuroscience Drug Development Veteran Dr. Douglas J. Williamson To Board Of Directors

Vistagen appoints Dr. Douglas J. Williamson, veteran neuroscience drug developer, to its Board of Directors to support its pherine pipeline.

Simantini Singh Deo | Aug 01, 2026